Thin Film Drug Manufacturing Market Is Expected to Be Worth US$ 15,984.3 Million by the End of 2024
The global thin film drug manufacturing market has been witnessing healthy competition on account of a wave of consolidation among existing players. Some such prominent players operating in the market are MonoSol Rx, Indivior Plc., ZIM Laboratories Limited., and IntelGenx Corp.
View full press release